Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Gynecol Oncol. 2013 Jan 13;129(1):86–91. doi: 10.1016/j.ygyno.2013.01.006

Table 3.

Responses (n=22)

No. %a
Partial responsea 1 5
Stable disease 7 32
Progressive disease 2 9
Indeterminateb 12b, 55
a

% sums to 101% due to rounding of to the nearest whole number.

b

Seven patients were indeterminate because study treatment was terminated early.